ACTHIV 2012 - FREE - CME/CNE-Certified Web Curriculum
Release Date: June 25, 2012
Expiration Date: June 25, 2013
The activities in this curriculum were originally presented as part of the American Conference for the Treatment of HIV (ACTHIV) 2012 Annual Conference, which was held May 10-12, 2012 in Denver, CO. The conference as well as the web curriculum were supported by funding from the Office of AIDS Research of the National Institutes of Health. In addition, the educational portion of the conference as well as the web curriculum were supported by educational grants from Bristol-Myers Squibb, Gilead Sciences, and ViiV Healthcare.
Activities in this curriculum include:

U.S. Community-Based Epidemiology— Implications for Clinical Practice
Richard Moore, MD, Professor of Medicine, The Johns Hopkins University School of Medicine.
Learning Objectives:
• Identify how the epidemiology of HIV-infection is evolving in the U.S.
• Describe how different sub-populations with HIV are being affected
• Adapt your practice to the changes in clinical epidemiology
Estimated time to complete: 45 minutes

HIV Primary Care Guidelines
Judith A. Aberg, MD, FIDSA, FACP, Director of Infectious Diseases and Immunology, New York University School of Medicine, Bellevue Hospital Center
Learning Objectives:
• Discuss the initial evaluation and laboratory testing to be performed in HIV infected persons
• Apply primary care guidelines for the general population to those with HIV infection
Estimated time to complete: 30 minutes

Mental Health and Neurocognitive Screening in HIV Care
Francine Cournos, MD, Professor of Clinical Psychiatry, Columbia University; Principal Investigator, New York/ New Jersey AETC
Learning Objectives:
• Improve your skills in the differential diagnosis of altered mental status in HIV positive patients
• Select screening tools that will aid you in making neuropsychiatric diagnoses
Estimated time to complete: 30 minutes

Special Considerations in HIV Care and Prevention for Women
Monica Gandhi, MD, MPH, Associate Professor of Medicine, Division of HIV/AIDS, University of California, San Francisco
Learning Objectives:
• Describe sex differences in HIV progression and treatment outcomes
• Cite important updates in HIV prevention for women over the past two years
Estimated time to complete: 30 minutes

Complications of ART and Key Drug Interactions
Sally Hodder, MD, Professor of Medicine, Director of HIV Programs and Vice-chair, Department of Medicine at The New Jersey Medical School of the University of Medicine and Dentistry of New Jersey
Learning Objectives:
• Describe key complications of antiretroviral agents and the importance of customizing antiretroviral therapy to individual patients
• Identify key drug interactions of antiretroviral agents
Estimated time to complete: 30 minutes

Viral Hepatitis and HIV
Norah Ann Terrault, MD, MPH, Professor of Medicine and Surgery, Director of the Viral Hepatitis Center, University of California San Francisco
Learning Objectives:
• Describe the burden of liver disease related to HBV and HCV in patients living with HIV
• Recognize the factors – especially those that are modifiable - influencing progression of liver disease and risk of cirrhosis and hepatocellular carcinoma in coinfected patients
• Understand treatment options for HBV and HCV and the expected outcomes of these treatments in HIV patients
Estimated time to complete: 45 minutes
TARGET AUDIENCE
Physicians (both specialists and primary care/family medicine), nurse practitioners, and nurses who are frontline providers of care to persons at risk of or with HIV infection. Other healthcare professionals, including physician assistants, pharmacists, and case managers, involved in caring for these individuals may also participate.
JOINT SPONSORS
The enduring material is jointly sponsored by William Beaumont Hospital, American Academy of CME, Inc., and the American Conference for the Treatment of HIV (ACTHIV).